1. Betz E, Hämmerle H, Kling D, Lenke D, Müller CD (1986) The actions of verapamil on the model of arteriosclerosis. In: J Rosenthal (Ed) Calcium antagonists and hypertension: current status. Excerpta Medica, 83–96
2. Betz E, Kling D (1987) The effect of anipamil on the permeability of arterial endothelium. Internat Symp on Calcium Antagonists, New York, February 10-13, Abstractbook 54
3. Bielenberg GW, Beck T, Haubruck H, Krieglstein J (1986) Effects of calcium entry blocker emopamil on postischemic energy metabolism of the isolated perfused rat brain and on local cerebral blood flow in the conscious rat. In: J Krieglstein (Ed) Pharmacology of cerebral ischemia. Elsevier Science Publishers Amsterdam New York Oxford, 309–315
4. Corsini A, Granata A, Fumagalli R, Paoletti R (1986) Calcium antagonists and low density lipoproteins metabolism by human fibroblasts and by human hepatoma cell line HEP G2. Pharmacol Res Comm 18: 1–16
5. Curtis MJ, Walker MJA, Yuswack T (1986) Actions of the verapamil analogues, anipamil and ronipamil, against ischaemia-induced arrhythmias in conscious rats. Br J Pharmac 88: 355–361